Draxxin Injectable Solution is an antibiotic indicated for the treatment of bovine respiratory disease (BRD), infectious bovine keratoconjunctivitis (IBK) and foot rot in beef and non-lactating dairy cattle and for treatment and control of swine respiratory disease (SRD) in swine. Each ml contains 100 mg tulathromycin. The usual recommended dosage of Draxxin is 2.5 mg per kg (1.1 ml per 100 lbs) body weight, given in the neck. Do not administer more than 10 ml SQ per injection site in cattle. One dose provides up to 7-14 days BRD treatment and control. Do not administer more than 5 ml IM per injection site in swine. Not for use in female dairy cattle 20 months of age or older, or in calves to be processed for veal. Tulathromycin.
DRAXXIN (tulathromycin injection) Injectable Solution is an anti-infective approved for the treatment of bovine respiratory disease (BRD) caused by all four major bacterial pathogens, including Mycoplasma bovis and infectious bovine keratoconjunctivitis (pinkeye) in non-lactating beef anddairy cattle (including calves) and veal calves. DRAXXIN is also labeled for the treatment of foot rot.
Indications
DRAXXIN Injectable Solution is indicated for the following: treatment of bovine respiratory disease (BRD) associated with Mannheimia haemolytica, Pasteurella multocida, Histophilus somni and Mycoplasma bovis; and for the control of respiratory disease in cattle at high risk of developing BRD associated with M. haemolytica, P. multocida, H. somni and Mycoplasma bovis; for the treatment of infectious bovine keratoconjunctivitis (pinkeye) associated with Moraxella bovis; and for the treatment of interdigital necrobacillosis (bovine foot rot) associated with Fusobacterium necrophorum and Porphyromonas levii.
BRD – Draxxin Injectable Solution is indicated for the treatment of bovine respiratory disease (BRD) associated with Mannheimia haemolytica, Pasteurella multocida, Histophilus somni, and Mycoplasma bovis; and for the control of respiratory disease in cattle at high risk of developing BRD associated with Mannheimia haemolytica, Pasteurella multocida, Histophilus somni, and Mycoplasma bovis. IBK – Draxxin Injectable Solution is indicated for the treatment of infectious bovine keratoconjunctivitis (IBK) associated with Moraxella bovis.
Foot Rot – Draxxin Injectable Solution is indicated for the treatment of bovine foot rot (interdigital necrobacillosis) associated with Fusobacterium necrophorum and Porphyromonas levii.
SRD – Draxxin Injectable Solution is indicated for the treatment of swine respiratory disease (SRD) associated with Actinobacillus pleuropneumoniae, Pasteurella multocida, Bordetella bronchiseptica, Haemophilus parasuis, and Mycoplasma hyopneumoniae; and for the control of SRD associated with Actinobacillus pleuropneumoniae, Pasteurella multocida, and Mycoplasma hyopneumoniae in groups of pigs where SRD has been diagnosed.
Reviews
There are no reviews yet.